Plague

Dermatologic Clinics

Volumn 22, Issue 3, 2004, Pages 303-312

  Cobbs, C Glenn ^a   Chansolme, David H ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL VACCINE; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CHLORAMPHENICOL; DOXYCYCLINE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE;

BACTEREMIA; BACTERIUM CULTURE; BIOLOGICAL WARFARE; CYANOSIS; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHADENOPATHY; MICROSCOPY; MORBIDITY; MORTALITY; NONHUMAN; PHARYNGITIS; PLAGUE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPTICEMIA; SIDE EFFECT; THORAX PAIN; VIRUS INFECTION; VIRUS MENINGITIS; VIRUS PNEUMONIA; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; YERSINIA PESTIS;

ANTI-BACTERIAL AGENTS; BIOTERRORISM; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; MALE; PLAGUE; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES; YERSINIA PESTIS;

EID: 2942652395     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.03.007     Document Type: Review

References (36)

1. Drancourt M., Raoult D. Molecular insights into the history of plague. Microbes Infect. 4:2002;105-109
2. Aleksic S., Bockemühl J. Yersinia and other Enterobacteriaceae. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. Manual of clinical microbiology. 7th edition:1999;483-496 ASM Press, Washington (DC)
3. Plague and Meliodosis. Manson-Bahr P.E.C., Bell D.R. Manson's tropical diseases. 19th edition:1987;586-606 Ballière Tindall, London
4. Swartz M.N. Yersinia, Francisella, Pasteurella, & Brucella. Davis B., Dulbecco R., Eisen H.N., Ginsberg H.S. Microbiology. 4th edition:1990;601-614 JB Lippincott Co. Philadelphia
5. Yersinia. Joklik W.K., Willett H.P., Amos D.B., Wilfert C.M. Zinsser Microbiology. 20th edition:1992;584-594 Appleton & Lange, Norwalk (CT)
6. th edition:1984;340-348 WB Saunders, Philadelphia
7. Perry R.D. A plague of fleas - survival and transmission of Yersinia pestis. Am Soc Microbiol News. 69(7):2003;336-340
8. Radnedge L., Agron P.G., Worsham P.L., Andersen G.L. Genome plasticity in Yersinia pestis. Microbiology. 148:2002;1687-1698
9. Butler T., Bell W.R., Linh N.N., Tiep N.D., Arnold K. Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis. 129:1974;S78-S84
10. World Health Organization Plague manual: epidemiology, distribution, surveillance, and control. Available at http://www.who.int/emc-documents/plague/ whocdscsredc992c.html. Accessed October 12, 2003
11. Gage K.L., Dennis D.T., Orloski K.A., Ettestad P., Brown T.L., Reynolds P.J., et al. Cases of cat-associated human plague in the Western US, 1977-98. Clin Infect Dis. 30:2000;893-900
12. Centers for Disease Control and Prevention Summary of notifiable disease, United States, 2000. MMWR Morb Mortal Wkly Rep. 49(53):2000;xvii
13. Cunha B.A. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Infect. 8:2002;489-503
14. Varkey P., Poland G.A., Cockerill F.R. III, Smith T.F., Hagen P.T. Confronting bioterrorism: physicians on the front line. Mayo Clin Proc. 77:2002;661-672
15. Centers for Disease Control and Prevention Recognition of illness associated with the intentional release of a biologic agent. MMWR Morb Mortal Wkly Rep. 50(41):2001;893-897
16. Butler T. A clinical study of bubonic plague: observations of the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med. 53:1972;268-276
17. Ratsitorahina M., Rabarijaona L., Chanteau S., Boisier P. Seroepidemiology of human plague in the Madagascar highlands. Trop Med Int Health. 5(2):2000;94-98
18. Centers for Disease Control and Prevention Laboratory response network. Level A laboratory procedures for identification of Yersinia pestis. Available at http://www.bt.cdc.gov/Agent/Plague/ype_la_cp_121301.pdf. Accessed November 29, 2003
19. Williams J.E., Arntzen L., Robinson D.M., Cavanaugh D.C., Isaäcson M. Comparison of passive haemagglutination and enzyme-linked immunosorbent assay for serodiagnosis of plague. Bull World Health Organ. 60(5):1982;777-781
20. William J.E., Atas M., Cavanaugh D.C. A comparison of serological tests for detecting antibody to plague. Bull World Health Organ. 54:1976;232-233
21. Williams J.E., Gentry M.K., Braden C.A., Tyndal G.L., Altieri P.L., Berman S., et al. A monoclonal antibody for the specific diagnosis of plague. Bull World Health Organ. 66(1):1988;77-82
22. Centers for Disease Control and Prevention Division of vector-borne infectious diseases. Laboratory test criteria for diagnosis of plague. Available at http://www.cdc.gov/ncidod/dvbid/plague/lab-test-criteria.htm. Accessed November 15, 2003
23. Butler T., Hudson B.W. The serological response to Yersinia pestis infection. Bull World Health Organ. 55:1977;39-42
24. Loïez C., Herwegh S., Wallet F., Armand S., Guinet F., Courcul R.J. Detection of Yersinia pestis in sputum by real-time PCR. J Clin Microbiol. 41(10):2003;4873-4875
25. Engelthaler D.M., Gage K.L., Montenieri J.A., Chu M., Carter L.C. PCR detection of Yersinia pestis in fleas: comparison with mouse inoculation. J Clin Microbiol. 37(6):1999;1980-1984
26. Bonacarsi S.P., Scavizzi M.R., Guiyole A., Amouroux J.H., Carniel E. Assessment of a flouroquinolone, three β-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother. 38(3):1994;481-486
27. Frean J., Klugman K.P., Arntzen L., Bukofzer S. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents. J Antimicrob Chemother. 52:2003;294-296
28. Galimand M., Guiyole A., Gerbaud G., Rasoamanana B., Chanteau S., Carniel E., et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 337(10):1997;677-680
29. Cavanaugh D.C., Elisberg B.L., Llewellyn C.H., Marshall J.D. Jr., Rust J.H. Jr., Williams J.E., et al. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J Infect Dis. 129:1974;S37-S40
30. Meyer K.F., Smith G., Foster L.E., Marshall J.D. Jr., Cavanaugh D.C. Plague immunization. IV. clinical reactions and serologic response to inoculations of haffkine and freeze-dried plague vaccine. J Infect Dis. 129:1974;S30-S36
31. Marshall J.S. Jr., Cavanaugh D.C., Bartelloni P.J., Meyer K.F. Plague immunization. III. Serologic response to multiple inoculations of vaccine. J Infect Dis. 129:1974;S26-S29
32. Meyer K.F., Hightower J.A., McCrumb F.R. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. J Infect Dis. 129:1974;S41-S45
33. Reddin K.M., Easterbrook T.J., Eley S.M., Russell P., Mobsby V.A., Jones D.H., et al. Comparison of the immunological and protective responses elicited by microencapsulated formulations of the FI antigen from Yersinia pestis. Vaccine. 16(8):1998;761-767
34. Wheelis M. Biological warfare at the 1346 Siege of Caffa. Emerg Infect Dis. 8(9):2002;971-975
35. Atlas R.M. Bioterrorism: from threat to reality. Annu Rev Microbiol. 56:2002;167-185
36. Tjaden J.A., Lazarus A.A., Martin G.J. Bacteria as agents of biowarfare: how to proceed when the worst is suspected. Postgrad Med. 112(2):2002;57-70